Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA)

R&D Expenses

$995.00M

TTM · Period ending: Jun 30, 2026 · USD

TEVA R&D Expenses

Latest reported$995.00Mperiod endingJun 30, 2026

TEVA TTM R&D Expenses ($0.00 → $995.00M)

TTM R&D Expenses

High-resolution chart · PNG

TEVA r&d expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Teva Pharmaceutical Industries Limited American Depositary Shares R&D Expenses — Trailing twelve months (TTM) (USD)
Period ending	R&D Expenses (USD)
Jun 30, 2026	995,000,000
Mar 31, 2026	989,000,000
Dec 31, 2025	1,014,000,000
Sep 30, 2025	1,018,000,000
Jun 30, 2025	1,002,000,000
Mar 31, 2025	1,027,000,000
Dec 31, 2024	1,022,000,000
Sep 30, 2024	985,000,000
Jun 30, 2024	998,000,000
Mar 31, 2024	1,004,000,000
Dec 31, 2023	1,015,000,000
Sep 30, 2023	991,000,000
Jun 30, 2023	913,000,000
Mar 31, 2023	866,000,000
Dec 31, 2022	838,000,000
Sep 30, 2022	872,000,000
Jun 30, 2022	919,000,000
Mar 31, 2022	939,000,000
Dec 31, 2021	968,000,000
Sep 30, 2021	1,106,000,000
Jun 30, 2021	1,142,000,000
Mar 31, 2021	1,119,000,000
Dec 31, 2020	1,086,000,000
Sep 30, 2020	1,078,000,000
Jun 30, 2020	1,060,000,000
Mar 31, 2020	1,111,000,000
Dec 31, 2019	1,151,000,000
Sep 30, 2019	1,072,000,000
Jun 30, 2019	1,143,000,000
Mar 31, 2019	1,157,000,000
Dec 31, 2018	1,213,000,000
Sep 30, 2018	1,278,000,000
Jun 30, 2018	1,512,000,000
Mar 31, 2018	1,708,000,000
Dec 31, 2017	1,848,000,000
Sep 30, 2017	2,172,000,000
Jun 30, 2017	2,290,000,000
Mar 31, 2017	2,179,000,000
Dec 31, 2016	2,111,000,000
Sep 30, 2016	1,873,000,000
Jun 30, 2016	1,571,000,000
Mar 31, 2016	1,582,000,000
Dec 31, 2015	1,525,000,000
Sep 30, 2015	1,458,000,000
Jun 30, 2015	1,509,000,000
Mar 31, 2015	1,467,000,000
Dec 31, 2014	1,488,000,000
Sep 30, 2014	1,520,000,000
Jun 30, 2014	1,456,000,000
Mar 31, 2014	1,451,000,000
Dec 31, 2013	1,427,000,000
Sep 30, 2013	1,458,000,000
Jun 30, 2013	1,434,000,000
Mar 31, 2013	1,393,000,000
Dec 31, 2012	1,356,000,000
Sep 30, 2012	1,300,000,000
Jun 30, 2012	1,203,000,000
Mar 31, 2012	1,148,000,000
Dec 31, 2011	1,095,000,000
Sep 30, 2011	979,000,000
Jun 30, 2011	991,000,000
Mar 31, 2011	965,000,000
Dec 31, 2010	937,000,000
Sep 30, 2010	886,000,000
Jun 30, 2010	842,000,000
Mar 31, 2010	794,000,000
Dec 31, 2009	802,000,000
Sep 30, 2009	2,200,000,000
Jun 30, 2009	2,199,000,000
Mar 31, 2009	2,228,000,000
Dec 31, 2008	2,188,000,000
Sep 30, 2008	739,000,000
Jun 30, 2008	686,000,000
Mar 31, 2008	625,000,000
Dec 31, 2007	581,000,000
Sep 30, 2007	550,300,000
Jun 30, 2007	543,600,000
Mar 31, 2007	527,200,000
Dec 31, 2006	495,000,000
Sep 30, 2006	455,500,000
Jun 30, 2006	413,600,000
Mar 31, 2006	383,500,000
Dec 31, 2005	368,900,000
Sep 30, 2005	363,800,000
Jun 30, 2005	361,800,000
Mar 31, 2005	358,500,000
Dec 31, 2004	338,400,000
Sep 30, 2004	309,500,000
Jun 30, 2004	273,900,000
Mar 31, 2004	235,200,000
Dec 31, 2003	213,500,000
Sep 30, 2003	202,200,000
Jun 30, 2003	188,000,000
Mar 31, 2003	176,300,000
Dec 31, 2002	165,000,000
Sep 30, 2002	142,073,000
May 31, 2002	123,973,000
Mar 31, 2002	114,291,000
Dec 31, 2001	107,189,000
Sep 30, 2001	108,336,000